Back

Early initiation of SGLT2-inhibitors and changes in physical function in elderly patients hospitalized for heart failure

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in acute heart failure - pharmacotherapy (2) Pharmacotherapy Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Yosuke Nishihata

St. Luke's International Hospital, Tokyo (Japan)

5 More presentations in this session

Presentation thumbnail
Impact of an educational intervention on pharmacological management of HFrEF in Italy: results from the multicenter OpTIMa-HF registry
Doctor M. Di Santo (Naples, IT)
Abstract
Presentation thumbnail
Renal function and therapeutic inertia: a gap between eligibility and prescription of guideline-directed medical therapy in hospitalized reduced and mildly reduced ejection fraction patients
Doctor M. Silva (Amadora, PT)
Abstract
Presentation thumbnail
Natriuretic response as a marker of decongestion in hospitalized patients with heart failure
Doctor S. Singh (Hartford, US)
Abstract
Presentation thumbnail
No phenotype-based differences in discharge GDMT across the LVEF spectrum in acute heart failure: data from multicenter registry
Doctor M. Balabayeva (Aktobe, KZ)
Abstract
Presentation thumbnail
What are the treatment attributes preferred by UK patients with transthyretin amyloid cardiomyopathy?
Doctor L. Baig (London, GB)
Abstract

Access the full session

Session thumbnail
ePosters in acute heart failure - pharmacotherapy (2)

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice
thumbnail
Congress Session
Devices in acute heart failure
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources